Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Bullboard Posts
Post by hopefullon May 10, 2019 7:45am
109 Views
Post# 29732927

Molemate not so new?

Molemate not so new?So I did my DD, on the advice of insightful I spoke to the CEO of Vida. During the discussion, I asked him about the lack of presence on the net and else where , he explained the reason for this is that they have a large team working on the web site which seems to be more like a platform that will host more than just information. He assured me that this will be up shortly and that more light will come out of what is happening in Brazil.

i have been diving deep into this Medx seeing how they still are not sharing a lot, and now understand from this conversation that everything is tight to the vest so when it does come to light I believe will explode. Sooooo to this dive I came across another company who also had Molemate by the name of Astron clinics and eventually bought out by Biocompatibles. Below is what I found in the acknowledgements of this study which was conducted in the UK in 2010.

So now I have more questions. What and who hold the trademarks. Is Biocampatibles at all in this equation for Medx and how did this go unnoticed,and more importantly, why did Astron Clinica go down.  For someone who has lost a close member of my family to cancer I grow weary of everywhere in this field the notion of lets hurry up and wait. I want nothing more than this technology out there ASAP to save lives. Why is the media not picking up on this in a greater way.

here is the link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881908/

Excerpt:
Initiallyrtantly  MoleMate™, Astron Clinica, SIAscopy, SIAscan and SIAscope were trademarks of Astron Clinica Limited, which kindly supplied the MoleMate systems for this trial. In August 2009, Astron Clinica Ltd was taken over by Biocompatibles International plc, which now holds these trademarks.
Bullboard Posts